None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: american society of anaesthesiologist (ASA ) GRADE 1 & 2 AGE 18-65 YEARS MALE AND FEMALE PATIENTS BMI LAPAROSCOPIC SURGERIES
Exclusion criteria
Exclusion criteria: PATIENTS REFUSAL TO THE PROCEDURE PRIOR HISTORY OF MOTION SICKNESS/PONV HISTORY OF ALLERGIC REACTION TO PRPOFOL ADMINISTRATION OF ANTIEMETIC BEFORE SURGERY HISTORY OF CARDIAC/NEUROLOGICAL/GASTROINTESTINAL /RENAL AND HEPATIC DISEASES
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO COMPARE THE SUB HYPNOTIC DOSES OF PROPOFOL 10 MG, 20 MG,30 MG FOR PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOLLOWING LAPAROSCOPIC SURGERIESTimepoint: TO COMPARE THE SUB HYPNOTIC DOSES OF PROPOFOL 10 MG, 20 MG,30 MG FOR PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOLLOWING LAPAROSCOPIC SURGERIES in 108 patients in this three years of study | — |
Secondary
| Measure | Time frame |
|---|---|
| HEMODYNAMIC MONITORING INCIDENCE AND SEVERITY OF NAUSEA AND VOMITING SEDATION IN THESE GROUPS ANY ASOOCIATED SIDE EFFECTSTimepoint: 24 HOURS | — |
Countries
India
Contacts
chettinad academy of research and education